The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
none considered needed
Study Type
OBSERVATIONAL
Enrollment
700
SUS
Stavanger, Norway
RECRUITINGClinical efficacy of IBD drug therapy
Endoscopic, clinical and biochemical response
Time frame: 5 years
Fatigue in patients with coeliac disease - substudy
Fatigue severity and prevalence at diagnosis and after one year of gluten free diet
Time frame: 1 year
Fatigue in IBD
Fatigue severity and prevalence at diagnosis and during follow-up
Time frame: 5 years
IBD and the intestinal microbiome
Microbiome/eukaryome profiles associated with disease activity and treatment response from diagnosis and during follow-up
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.